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Abstract Introduction: The aim of this investigation was to provide evidence that
leukocyte depleted whole blood meets the requirements for transfusion of the
European Council and thus may be an alternative to leukocyte and plasma depleted
packed red blood cells in autologous blood predeposit for patients undergoing elec-
tive surgery programs.
Material and methods: Standard units of 450 mL blood were collected from 25
healthy male volunteers. Leukocyte depletion was done via inline filtration 4 h
after collection. Storage lesion was assessed by measuring the release of Kþ,
LDH, free hemoglobin, and lactate into the storage medium, as well as by the in-
crease of hemolysis, the decrease of pH and consumption of glucose over a storage
period of 35 days. As surrogate marker for red cell quality the intracellular concen-
trations of adenine nucleotides [ATP, ADP, AMP] were determined.
Results: The extent of storage lesion remained within the ranges of standard liquid
storage conditions. Hemolysis was far below the threshold of 0.8% in all WB units at
the end of their shelf life. Only minor changes of intracellular adenine nucleotide
levels were measured indicating a preserved function of red blood cells in leuko-
cyte depleted whole blood. At the end of shelf life 70% 18% of initial ATP levels
were detected.
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180 G.C. Leitner et al.Conclusion: Based on our data we propose that leukocyte depleted whole blood,
stored for 35 days can be an option in the autologous blood supply as it meets
the requirements for transfusion of the European Council.
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Preoperative autologous blood donation is a well
established procedure in elective surgery
programs.1,2 The production and storage of autolo-
gous blood components are recommended by the
European Guidelines to follow the same rules as
the production and storage of homologous blood
components.3 Thereby collected whole blood is
plasma and leukocyte depleted in order tominimise
the occurrence of adverse reactions in the trans-
fused patient, i.e. allergic reactions, febrile non-
haemolytic transfusion reactions (FNHTR) and
transfusion related lung injury, due to alloproteins,
cytokines and antibodies against granulocytes or
HLA.4e6 While FNHTR due to cytokines can occur
in both, in the homologous and autologous setting
adverse reactions caused by the plasma fraction
are mainly a problem of the homologous setting.
Production of Leukocyte depleted whole blood
(LDWB) is a time and cost sparing procedure. After
leukocyte depletion LDWB is storedwithout further
manipulation.
Here we investigated whether LD WB units
stored for 35 days meet the requirements for
transfusion of the European Guidelines and can
be an option in the autologous setting.7 The qual-
ity of stored red blood cells (RBC) was assessed
by measuring the release of Kþ, LDH, and free
hemoglobin (fHb) into the supernatant over time
as well as by the increase of hemolysis and the
decrease of glucose and pH till the end of shelf
life. We paid special attention to the intracellular
adenine nucleotide content considering the latter
as surrogate marker for red cell quality.8
Donors and methods
Donors
Twenty five healthy male donors (median age 40
years, range 22e64 years) recruited from our
donor pool underwent whole blood donation. All
donors met the European criteria for eligibility for
whole blood donors and written informed consent
to participate in the study was obtained. Standard
units of whole blood (450 mL) were collected from
each donor into a double blood bag system[MacoPharma, Toucoing, France] with an integrated
filter (Leucoflex, MacoPharma, Toucoing, France)
between collection bag and final storage bag rep-
resenting a closed system.
Collection and filtration procedure
The collection bag, containing 70 mL CPDA-1 anti-
coagulant/preservative solution, and the final
storage bag were labelled before the beginning of
collection. WB and anticoagulant were mixed
thoroughly immediately after beginning and
throughout the entire collection procedure using
an automated blood mixer (Optimix, Baxter). All
units were kept at room temperature for at least
4 h to ensure bacterial phagocytosis and were leu-
kocyte depleted via inline filtration thereafter.
The storage bag was disconnected from the filter
using a sterile disconnection device (Composeal,
NPBI International BV Fresenius HemoCare, Nether-
lands). WB units were stored at 4 C for 35 days
(blood refrigerator, Dometic, Medical Systems,
U.S.A.). Blood bags, solutions and filter systems
are CE marked (CE 0123) and approved by the Paul
Ehrlich Institute (German) for the use of blood
products.
Laboratory analyses
Samples were drawn under aseptical conditions for
the determination of red blood cell counts and
parameters indicating storage lesion immediately
after leukocyte depletion on day 0 and subse-
quently at weekly intervals until the end of the
shelf life on day 35. Kþ, LDH, and free hemogobin
(fHb) contents in the supernatant were deter-
mined using a Hitachi 917 spectrophotometer
(Boehringer Mannheim, Mannheim, Germany). Lin-
ear detection limits ranged between 0.5 mg/dl and
500 mg/dl for fHb and between 6 and 1200 U/L for
LDH. Glucose was analyzed enzymatically by the
hexokinase assay (Olympus System Reagent/Olym-
pus Diagnostica, Ireland). Linear detection limits
ranged between 10 and 800 mg/dl for serum and
plasma. Lactate was determined using the lactate
assay on a Roche/Hitachi 917. All analyses were
done according to the manufacturer’s protocol.
Intracellular nucleotides (ATP, ADP and AMP)
were determined by high performance liquid
Whole blood for autologous blood predeposit 181chromatography (HPLC) as described previously.9
Blood cell counts were measured by a Cell Dyn
3500 device [Abbott Diagnostics, South Pasadena,
CA]. Residual white blood cells were determined
by flowcytometry [FACScan, Becton-Dickinson,
San Jose, CA] using the Leuko-Count kit [Bectone
Dickinson]. Hemolysis (%) was calculated as fol-
lows: [[fHb[100Hct]]/Hbtotal ]/1000.
The pH measurements were performed with the
pH Methrom [Methrom AG, Herisau, Switzerland]
at 20 C. Before each measurement the instru-
ment was calibrated to a pH-value between 4.0
and 7.4 using standards.
Ten PRBCs, conventionally prepared and SAGM
preserved,were used as a historical control group.10
PRBCs were stored under the same conditions as LD
WB. We compared the intracellular ATP concentra-
tion and hemolysis after a storage period of 35 days,
representing the end of shelf life for LD WB.
Statistics
Results are expressed as means standard devia-
tion for descriptive purposes in the text. Because
of the non-normal distribution of data, all compar-
isons were made by non-parametric statistics. All
statistical analyses were performed by using Fried-
man analysis of variance (ANOVA) test. A two tailed
p value< 0.05 was considered significant. For com-
parisons between LD WB and the historical control
group the ManneWhitney-U test was applied.
Results
Characteristics of whole blood units
The mean Hct and the mean hemoglobin levels
were 38.3% (3.6%) and 12.9 g/dL (1.1 g/dL),
respectively. Leukocyte contamination (mean
0.32 106 absolute, 0.3) was less than 1 106
leukocytes in all units.Metabolic parameters
Kþ, LDH, lactate and fHb increased in the superna-
tant over time, but the increase of RBC hemolysis
was below 0.8% in all units meeting the require-
ments for transfusion of the national and European
Guidelines. No significant difference was found be-
tween LD WB and historical control group (p¼ 0.6)
(Table 2). The pH levels decreased significantly
from initial 7.0 0.08 to 6.56 0.06 at the end
of shelf life (p< 0.05). Consumption of glucose
ranged between 52% and 70% of initial values till
day 35 (mean 60% 6). Values are detailed in
Table 1.
Intracellular nucleotides (ATP,
ADP, and AMP)
The intracellular content of ATP rose within 14
days from a mean of 122 (26) pmol/106 erythro-
cytes to a mean of 138 (33) pmol/106 erythro-
cytes (p< 0.05) and decreased thereafter. At the
end of shelf life 70% (18%) of the initial value
was found. ADP and AMP showed also an increase
until day 14 and day 28, respectively (p< 0.05)
and remained elevated until day 35. Initially 13
(2) pmol/106 erythrocytes of ADP and 7 (1.8)
pmol/106 erythrocytes of AMP were measured. At
the end of shelf life 258% (79%) of the initial
ADP content and 221% (74%) of initial AMP con-
tent were detected (p< 0.05) (Fig. 1).
At this time significant lower ATP levels
(p< 0.001) were detected in PRBCs (historical con-
trol group). Values are shown in Table 2.
Discussion
Patients undergoing elective surgery, e.g. hip,
knee, plastic surgery, may benefit from autologous
blood deposits if they are eligible for blood
donation.1,2 The limiting parameter for transfusionTable 1 Metabolic parameters, decrease of pH and increase of hemolysis in CPDA-1 preserved whole blood
Days 0 7 14 21 28 35
Kþ (mmol/L) 3.8 (0.8) 14.3 (4.0)* 17.2 (2.5)* 20 (2.5)* 22.9 (3.1)* 24.9 (3.2)*
LDH (U/L) 168 (61) 172 (60) 176 (61) 167 (48) 178 (66) 185 (65)
fHb (mg/dl) 16.6 (19.2) 28.9 (25.6) 29.3 (26.8) 34.4 (33.0) 35.4 (33.2) 37.8 (29.1)
Glucose (mg%) 482 (24) 406 (39) 370 (33) 344 (30) 314 (32) 291 (27)
Lactate (mmol/L) 3.18 (0.8) 10.4 (2.8) 13.9 (2.1) 17.7 (2.5) 20.8 (2.4) 22.6 (2.6)
pH 7.0 (0.08) 6.84 (0.08) 6.71 (0.05)* 6.64 (0.07)* 6.58 (0.04)* 6.56 (0.06)*
Hemolysis (%) 0.08 (0.09) 0.11 (0.1) 0.14 (0.1) 0.16 (0.175) 0.18 (0.17) 0.20 (0.15)
Values are expressed as mean and standard deviation. * Indicate statistical significant changes during the storage period with
a p value <0.05.
182 G.C. Leitner et al.of stored blood is the increase of hemolysis (re-
flected by the increase of Kþ, LDH and fHb) and
is limited to 0.8% at the end of shelf life.7 In LD
WB units a RBC hemolysis of 0.2% 0.15% was mea-
sured on day 35 which is clearly below the thresh-
old but slightly higher than that in PRBCs (Table 2).
In the process to obtain PRBCs, plasma containing
free hemoglobin, is depleted after centrifugation
and replaced by additive solution. So artificial
lower initial values of fHb may account for this
observation. During storage erythrocytes have to
carry out certain energy requiring processes in
order to maintain membrane stability.8e10 This en-
ergy is provided mainly from glycolysis and its suf-
ficiency can be measured by the concentration of
ATP in erythrocytes and the consumption of glu-
cose.8 We found a significant initial increase of
the intracellular adenine nucleotides ATP, ADP
and AMP indicating a net synthesis of these nucleo-
tides due to the presence of adenine in the storage
medium and a high rate of glycolysis during the
first two weeks. During further storage the ratio
of production vs. consumption changed towards
consumption and ATP levels decreased to
70% 18 of initial levels until the end of shelf
course of intracellular ATP, ADP and AMP in LD WB
during the storage of 35 days
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Figure 1 This figure shows the intracellular ATP (-),
ADP ( ) and AMP (6) content given in pmol/106 erythro-
cytes in WB units throughout the storage period of 35
days. Asterisks indicate statistical significance with
a p value of <0.05.
Table 2 Hemolysis, intracellular ATP content of red
blood cells on day 35 of storage in LD WB vs. PRBC
LD WB
(n¼ 25)
PRBC
(n¼ 10)
p Value
Hemolysis (%) 0.2 15 0.14 0.05 0.6
ATP, pmol/106
red blood cells
89 16 58 8 0.001life which indicates less degradation compared to
conventionally produced PRBCs where 30% 4.9
of initial values were detected (Table 2). This
can be explained by omitting the centrifugation
step in order to split WB in its components. Shear
stress during production may lead to membrane
damage inducing enhanced energy requiring mem-
brane repair processes. In apheresis derived
PRBCs, which are also exposed to lower initial
membrane damage higher ATP levels were found
too at the end of shelf life.10e12
A satisfying glucose reserve remained at this
time. Sixty percent of glucose was utilized and
lactate was increased to 8 fold of initial values
which is also measured in PRBCs stored in additive
solutions.13 Simultaneously ADP and AMP levels
remained elevated. Enhanced loss of ADP was
found in PRBCs stored after irradiation, which is
known to induce membrane damage indicating
a high phosphorylation rate.9 Taken together, ele-
vated ADP and AMP values, well maintained intra-
cellular ATP levels as well as acceptable hemolysis
measured in stored LD WB at the end of shelf life
may account for less initial membrane damage by
omitting the centrifugation to split LD WB into its
components. As described previously, the 24 h re-
covery of transfused PRBCs correlates strongly
with red cell quality8 and is significantly affected
when ATP concentrations fall below 10% of initial
values.14
In conclusion we observed that red blood cells
stored as LD WB fulfil the requirements for trans-
fusion warranted by the European Council and the
in vitro assessed adequate quality of erythrocytes
allow the assumption that the 24 h post-transfusion
recovery will not be impaired by the storage of red
blood cells as LD WB. Thus storage and transfusion
of LD WB may be an option in the autologous blood
predeposit especially in small hospitals without the
technical and personnel equipment of a blood
transfusion centre.
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